TABLE 7.

Regions reaching suggestive significance level of 10^–5 by common variants analysis.

Identification	Chro	Regions	Gene	p-values in each population
platform
				Affy	Illumina	Omni	Onco	Human core	Fisher
Illumina	1	52,254,865–52,344,609	NRDC, MIR761	2.95 × 10–1	6.39 × 10–6	2.50 × 10–1	1.13 × 10–1	4.91 × 10–1	1.29 × 10–4
	2	190,627,505–190,630,282	OSGEPL1-AS1	3.97 × 10–1	7.95 × 10–6	8.37 × 10–1	8.93 × 10–1	8.73 × 10–1	3.50 × 10–3
	2	190,634,992–190,649,097	ORMDL1	4.16 × 10–1	4.94 × 10–6	7.25 × 10–1	9.57 × 10–1	8.96 × 10–1	2.47 × 10–3
	2	190,648,810–190,742,355	PMS1	4.15 × 10–1	4.93 × 10–6	7.25 × 10–1	9.57 × 10–1	8.96 × 10–1	2.47 × 10–3
Omni	16	89,762,764–89,768,121	SPATA2L	7.03 × 10–1	2.56 × 10–2	4.96 × 10–6	2.77 × 10–2	1.96 × 10–1	5.19 × 10–6
Fisher	21	42,513,426–42,519,991	LINC00323	5.21 × 10–1	7.41 × 10–3	1.11 × 10–5	3.02 × 10–1	5.87 × 10–2	7.54 × 10–6

No regions were genome-wide significant after Bonferroni adjustment.

Bold values indicate suggestive association in the discovery phase or nominal significant association in the replication phase.